AIDA protocol

chemotherapy protocol consisting of all-trans retinoic acid and idarubicin; used against acute promyelocytic leukemia

Also Known As:

LPA96 protocol; LPA99 protocol; PETHEMA LPA96 protocol; PETHEMA LPA99 protocol

Networked: 8 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AIDA protocol: 8
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AIDA protocol: 8
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - AIDA protocol: 8
Organic Chemicals: 133
- Hydrocarbons: 1713
Biological Factors: 2472
- Biological Pigments: 1
  - Carotenoids: 4095
    - Retinoids: 5957
      - Tretinoin: 11074
        AIDA protocol: 8
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927
        AIDA protocol: 8
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Idarubicin: 927
        AIDA protocol: 8

Experts

1.	Breccia, M: 2 articles (05/2003 - 11/2002)
2.	Lo Coco, F: 2 articles (05/2003 - 11/2002)
3.	Mandelli, F: 2 articles (05/2003 - 11/2002)
4.	Domracheva, E V: 1 article (01/2013)
5.	Dvirnyk, V N: 1 article (01/2013)
6.	Galstian, G M: 1 article (01/2013)
7.	Kliasova, G A: 1 article (01/2013)
8.	Kuz'mina, L A: 1 article (01/2013)
9.	Parovichnikova, E N: 1 article (01/2013)
10.	Savchenko, V G: 1 article (01/2013)

Related Diseases

1.	Acute Promyelocytic Leukemia 07/01/2023 - "Acute promyelocytic leukemia in childhood and adolescence: treatment results of a modified AIDA protocol at a Brazilian center." 01/01/2013 - "To give the results of an investigation conducted at the Hematology Research Center (HRC), Ministry of Health of the Russian Federation (MHRF), to treat adult patients with acute promyelocytic leukemia (APL) according to the AIDA protocol elaborated by Spanish investigators. " 01/01/2013 - "[Treatment of adult patients with acute promyelocytic leukemia according to the AIDA protocol]." 12/01/2010 - "Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol." 01/01/2010 - "Treatment outcome of acute promyelocytic leukemia with modified aida protocol."
2.	Cardiotoxicity 07/01/2012 - "Subclinical anthracycline cardiotoxicity in patients with acute promyelocytic leukemia in long-term remission after the AIDA protocol." 07/01/2012 - "To investigate whether the AIDA protocol, which combines idarubicin, mitoxantrone, and all-trans retinoic acid (ATRA) for treatment of acute promyelocytic leukemia (APL) results in late cardiotoxicity, 34 APL patients in long-term remission were evaluated. "
3.	Disease Progression 05/01/2003 - "We analysed in this study the incidence and type of infections complicating the clinical course of 89 consecutive APL patients receiving the AIDA protocol at a single institution. "
4.	Infections 05/01/2003 - "We analysed in this study the incidence and type of infections complicating the clinical course of 89 consecutive APL patients receiving the AIDA protocol at a single institution. "

Related Drugs and Biologics

1.	Anthracyclines
2.	Idarubicin (4 Demethoxydaunorubicin)
3.	Tretinoin (Retinoic Acid)
4.	Mitoxantrone (Novantrone)
5.	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein